POSOCCO, BIANCA
 Distribuzione geografica
Continente #
NA - Nord America 764
AS - Asia 203
EU - Europa 112
SA - Sud America 1
Totale 1.080
Nazione #
US - Stati Uniti d'America 761
CN - Cina 105
SG - Singapore 85
IT - Italia 39
FI - Finlandia 20
DE - Germania 15
FR - Francia 13
GB - Regno Unito 5
IE - Irlanda 5
CA - Canada 3
IN - India 3
LT - Lituania 3
SE - Svezia 3
TR - Turchia 3
UA - Ucraina 3
VN - Vietnam 3
AT - Austria 2
BE - Belgio 1
BR - Brasile 1
IR - Iran 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
PL - Polonia 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 1.080
Città #
Fairfield 104
Chandler 85
Singapore 78
Ashburn 52
Santa Clara 49
Houston 45
Cambridge 41
Ann Arbor 40
Seattle 39
Boardman 34
Woodbridge 34
Beijing 30
Wilmington 26
San Diego 19
New York 18
Helsinki 15
Medford 14
Princeton 14
Des Moines 7
Trieste 6
Guangzhou 5
Jinan 4
Padova 4
Ankara 3
Changsha 3
Hangzhou 3
Kharkiv 3
Nanjing 3
Norwalk 3
Ogden 3
Pordenone 3
Roxbury 3
Shenyang 3
Toronto 3
Belluno 2
Dalian 2
Fort Worth 2
Hefei 2
Jacksonville 2
Munich 2
Sacile 2
San Giorgio A Cremano 2
Taizhou 2
Tianjin 2
Vienna 2
Acton 1
Amsterdam 1
Brussels 1
Centro 1
Chengdu 1
Chiampo 1
Chiswick 1
Dezhou 1
Dublin 1
Esslingen am Neckar 1
Frankfurt am Main 1
Gdansk 1
Hanoi 1
Hebei 1
Hyderabad 1
Indiana 1
Jiaxing 1
Kunming 1
Lanzhou 1
Lappeenranta 1
London 1
Montegrotto Terme 1
Nanchang 1
Naples 1
Ningbo 1
Ocala 1
Prescot 1
Redmond 1
Rio Verde 1
Tashkent 1
Vientiane 1
Wenzhou 1
Zhengzhou 1
Zhoukou 1
Totale 852
Nome #
Light driven water oxidation by a single site cobalt salophen catalyst 118
NPQ activation reduces chlorophyll triplet state formation in the moss Physcomitrella patens 96
Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma 86
A new high-performance liquid chromatography–tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine 75
Cross-validation of a mass spectrometric-based method for the therapeutic drug monitoring of irinotecan: implementation of matrix-assisted laser desorption/ionization mass spectrometry in pharmacokinetic measurements 68
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 63
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients 57
A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma 55
An SPR investigation into the therapeutic drug monitoring of the anticancer drug imatinib with selective aptamers operating in human plasma 54
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer 46
Therapeutic drug monitoring of palbociclib, ribociclib and letrozole in women with breast cancer by LC-MS 44
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring 41
Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations 36
Field-assisted paper spray mass spectrometry for the quantitative evaluation of imatinib levels in plasma 32
Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine 30
The development of a matrix-assisted laser desorption/ionization (MALDI)-based analytical method for determination of irinotecan levels in human plasma: Preliminary results 30
Mass spectrometry in the pharmacokinetic studies of anticancer natural products 25
A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring 22
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring 16
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer 16
An Integrated Pharmacological Counselling Approach to Guide Decision-Making in the Treatment with CDK4/6 Inhibitors for Metastatic Breast Cancer 15
Bioanalytical Methods for Poly(ADP-Ribose) Polymerase Inhibitor Quantification: A Review for Therapeutic Drug Monitoring 12
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure 11
A fast and validated LC-MS/MS method to quantify lenvatinib in dried blood spot 11
Clinical impact of body mass index on palbociclib treatment outcomes and effect on exposure 10
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis 9
Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method 8
Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series 7
Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions 7
Matrix-assisted laser desorption/ionization, nanostructure-assisted laser desorption/ionization and carbon nanohorns in the detection of antineoplastic drugs. 1. The cases of irinotecan, sunitinib and 6-alpha-hydroxy paclitaxel 7
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring 4
Totale 1.111
Categoria #
all - tutte 6.781
article - articoli 6.781
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.562


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020117 0 0 0 0 0 6 19 22 18 25 12 15
2020/2021129 4 14 2 10 7 10 9 16 18 16 18 5
2021/2022184 8 20 13 11 4 28 10 16 9 14 15 36
2022/2023185 25 22 3 26 32 17 0 9 28 4 13 6
2023/2024122 6 16 6 11 9 27 11 6 10 3 11 6
2024/2025278 1 79 40 36 77 45 0 0 0 0 0 0
Totale 1.111